-+ 0.00%
-+ 0.00%
-+ 0.00%

Harmony Biosciences reiterates 2026 net product revenue guidance of $1-1.04 billion

PUBT·04/14/2026 12:10:18
Listen to the news
Harmony Biosciences reiterates 2026 net product revenue guidance of $1-1.04 billion
  • Harmony Biosciences reiterated 2026 net product revenue guidance of USD 1.0 billion to USD 1.04 billion.
  • Outlook reflects expectations for WAKIX net sales to exceed USD 1 billion in 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Harmony Biosciences Holdings Inc. published the original content used to generate this news brief on April 14, 2026, and is solely responsible for the information contained therein.